Objective: To investigate the mutational characteristics of cathepsin C (CTSC) gene in two Chinese patients with Papillon-Lefèvre syndrome (PLS), and provide molecular basis for research of the pathogenesis of PLS.

Methods: Peripheral blood samples were obtained from patients and their parents respectively. Genomic DNA were extracted after consents. Polymerase chain reaction, direct DNA sequencing and restriction enzyme reaction were performed to screen mutations of CTSC gene.

Results: Compound heterozygous mutations of CTSC gene were identified in the two patients. Patient I carried the G139R and S260P mutations, patient II had the R250X and C258W mutations. The parents were heterozygous carriers without the clinical feature of PLS. None of the mutations were detected in normal controls. Furthermore, the S260P and C258W changes were novel mutations of CTSC gene, which had not been reported previously.

Conclusions: Mutations of CTSC gene are responsible for the phenotype of Papillon-Lefèvre syndrome in two Chinese patients. The results extend the mutation spectrum of CTSC gene and also provide basis for gene diagnosis of PLS in China.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ctsc gene
20
mutations ctsc
16
chinese patients
12
gene chinese
8
patients papillon-lefèvre
8
papillon-lefèvre syndrome
8
gene
7
mutations
7
ctsc
6
patients
5

Similar Publications

A comprehensive analysis to reveal the underlying molecular mechanisms of natural killer cell in thyroid carcinoma based on single-cell RNA sequencing data.

Discov Oncol

January 2025

The Department of Experimental Medicine, Meishan City People's Hospital, No. 288, South Fourth Section, Dongpo Avenue, Meishan, 620000, Sichuan, China.

Background: Thyroid carcinoma (THCA) is the most common cancer of the endocrine system. Natural killer (NK) cell play an important role in tumor immune surveillance. The aim of this study was to explore the possible molecular mechanisms involved in NK cell in THCA to help the management and treatment of the disease.

View Article and Find Full Text PDF
Article Synopsis
  • Airway remodeling plays a crucial role in severe or uncontrolled asthma, influenced by epithelial-mesenchymal trophic units (EMTUs) activated by airway epithelial cells (AECs).
  • Researchers found that elevated levels of the gene Cathepsin C (CTSC) in asthma patients correlate with disease severity and airway remodeling, as shown through RNA sequencing and sputum analysis.
  • Targeting CTSC with a specific compound not only reduced inflammation but also inhibited EMTU activation and airway remodeling, highlighting its potential as a biomarker and treatment target for severe asthma.
View Article and Find Full Text PDF

Background: Cathepsin C (CTSC) participates in the development of numerous cancers; however, its function in bladder cancer (BCa) remains largely unknown.

Methods: Bioinformatics prediction, quantitative reverse transcription polymerase chain reaction (RT-qPCR) assay, and Western blot assay were used to determine CTSC expression in BCa tissues, paracancer tissues, BCa cells, and normal uroepithelial cells (SV-HUC-1). Colony formation, cell counting kit-8 (CCK-8), and Transwell assays were utilised to ascertain the involvement of CTSC in BCa.

View Article and Find Full Text PDF

Cathepsin C in health and disease: from structural insights to therapeutic prospects.

J Transl Med

August 2024

Center of Excellence in Genomics and Precision Dentistry, Department of Physiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, 10330, Thailand.

Article Synopsis
  • * The review covers the structure, function, and genetic variants of CTSC, linking them to several syndromes like Papillon-Lefevre syndrome, Haim-Munk Syndrome, and aggressive periodontitis, which involve skin and dental issues.
  • * CTSC's role in diseases like chronic obstructive pulmonary disease, COVID-19, and various cancers highlights its potential as a target for new therapies in autoimmune and inflammatory conditions.
View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory breast cancer (IBC) is a rare and aggressive type of breast cancer that contributes to 10% of breast cancer deaths, and this study aimed to explore its unique genetic characteristics compared to non-IBC cases.
  • The researchers analyzed data from a cohort of IBC and non-IBC patients using whole-exon sequencing and RNA sequencing to discover somatic genomic alterations and gene expression differences.
  • Findings revealed several genetic distinctions, including increased copy number variations and immune activation in IBC, with specific gene fusions and dysregulated RAS pathway signaling highlighted as potential therapeutic targets for treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!